SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001144204-17-003191
Filing Date
2017-01-20
Accepted
2017-01-20 16:40:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 424B3 v457150_424b3.htm 424B3 90298
  Complete submission text file 0001144204-17-003191.txt   91397
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-214889 | Film No.: 17538921
SIC: 2836 Biological Products, (No Diagnostic Substances)